33 results on '"Xia, Zhengyuan"'
Search Results
2. Non-coding RNAs modulate pyroptosis in myocardial ischemia-reperfusion injury: A comprehensive review
- Author
-
Sun, Yi, Chu, Shujuan, Wang, Rong, Xia, Rui, Sun, Meng, Gao, Zhixiong, Xia, Zhengyuan, Zhang, Yan, Dong, Siwei, and Wang, Tingting
- Published
- 2024
- Full Text
- View/download PDF
3. Kinsenoside mitigates myocardial ischemia/reperfusion-induced ferroptosis via activation of the Akt/Nrf2/HO-1 pathway
- Author
-
Wang, Rong, Dong, Siwei, Xia, Rui, Sun, Meng, Sun, Yi, Ren, Hong, Zhang, Yonghui, Xia, Zhengyuan, Yao, Shanglong, and Wang, Tingting
- Published
- 2023
- Full Text
- View/download PDF
4. EGFR promotes the apoptosis of CD4+ T lymphocytes through TBK1/Glut1 induced Warburg effect in sepsis
- Author
-
Huang, Li, Zhang, Xuedi, Fan, Junyu, Liu, Xiaolei, Luo, Shuhua, Cao, Dianqing, Liu, Youtan, Xia, Zhengyuan, Zhong, Hanhui, Chen, Cuiping, Zhang, Liangqing, Liu, Zhifeng, and Tang, Jing
- Published
- 2023
- Full Text
- View/download PDF
5. Transcriptome analyses unravel CYP1A1 and CYP1B1 as novel biomarkers for disinfection by-products (DBPs) derived from chlorinated algal organic matter
- Author
-
Wu, Binbin, Hong, Huachang, Xia, Zhengyuan, Liu, Hailong, Chen, Xi, Chen, Junhui, Yan, Bin, and Liang, Yan
- Published
- 2020
- Full Text
- View/download PDF
6. Ginsenosides compound (shen-fu) attenuates gastrointestinal injury and inhibits inflammatory response after cardiopulmonary bypass in patients with congenital heart disease
- Author
-
Xia, Zhong-Yuan, Liu, Xian-Yi, Zhan, Li-Ying, He, Yi-Hong, Luo, Tao, and Xia, Zhengyuan
- Subjects
Congenital heart disease -- Care and treatment ,Cardiac patients -- Care and treatment ,Heart diseases -- Care and treatment ,Genetic disorders -- Care and treatment ,Coronary artery bypass ,Health - Abstract
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.jtcvs.2005.02.046 Byline: Zhong-yuan Xia (a)(b), Xian-Yi Liu (a)(b), Li-ying Zhan (a)(b), Yi-hong He (a), Tao Luo (a)(b), Zhengyuan Xia (a)(b) Abstract: This study was undertaken to demonstrate that gastrointestinal mucosal injury occurs during cardiopulmonary bypass in children, increasing systemic inflammatory responses, and to determine whether shen-fu injection (the major components of which are ginsenosides compound, extract of Panax ginseng shown to have antioxidant properties) could attenuate gastrointestinal mucosal injury and subsequent inflammatory responses. Author Affiliation: (a) Anesthesiology Research Laboratory, Renmin Hospital, Wuhan University, Wuhan, People's Republic of China (b) Department of Anesthesiology, Renmin Hospital, Wuhan University, Wuhan, People's Republic of China Article History: Received 21 November 2004; Revised 26 January 2005; Accepted 7 February 2005
- Published
- 2005
7. Predictors of Short-term Outcomes Following Repair of Anomalous Origin of the Left Coronary Artery From the Pulmonary Artery in Chinese Children: A Case-Control Study.
- Author
-
Zhang, Chaobin, Luo, Qipeng, Li, Yinan, Wu, Xie, Hao, Zhang, Li, Shoujun, Xia, Zhengyuan, Yan, Fuxia, and Sun, Li
- Abstract
Objective To analyze the predictive factors associated with prolonged mechanical ventilation (PMV) and prolonged duration of inotropic support (PDIS) following anomalous origin of the left coronary artery from the pulmonary artery (ALCAPA) surgery with possible concomitant mitral valve procedure (MVP) in a relatively young population. Design A retrospective case-control study. Setting Fuwai hospital. Participants Pediatric patients with ALCAPA surgery from July 2010 to October 2017. Interventions None. Measurements and Main Results PMV was defined as a mechanical ventilation time ≥48 hours and PDIS as a duration of inotropic support ≥6 days. Univariate analysis, logistic regression analysis, and receiver operating characteristic curve analysis were used to identify independent predictors of PMV and PDIS. The independent predictors of PMV were found to be the left ventricular end-diastolic diameter z-score (LVEDDz), estimate of glomerular filtration rate (eGFR) and maximum vasoactive-inotropic score (VISm). The odds ratios and 95% confidence intervals for these predictors of PMV were the following: LVEDDz, 1.58 (1.19-2.09); eGFR, 0.96 (0.93-0.998); and VISm, 1.08 (1.01-1.17). The predictor of PDIS was LVEDDz at 1.65 (1.26-2.15). One patient died during hospitalization, and there was no reoperation. Thirty-seven patients received concomitant MVP with no hospital mortality. At discharge, mitral regurgitation (MR) had improved in all patients with MR. Patients with PMV were associated with more acute kidney injury, PDIS, and longer ICU and hospital stays. Conclusions In relatively young individuals who received ALCAPA surgery and possible concomitant MVP, short-term outcomes are favorable. Based on their experience bias, the authors recommend combining LVEDDz, eGFR, and VISm to predict PMV and applying LVEDDz for PDIS. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
8. Cardiac expression of adiponectin and its receptors in streptozotocin-induced diabetic rats.
- Author
-
Guo, Zhixin, Xia, Zhengyuan, Yuen, Violet G., and McNeill, John H.
- Subjects
DIABETES ,IMMUNOSUPPRESSIVE agents ,STREPTOZOTOCIN ,ANIMAL models in research - Abstract
Abstract: Adiponectin can improve both glucose metabolism and insulin resistance via the adenosine monophosphate–activated protein kinase (AMPK) signaling pathway. Activated AMPK phosphorylates a variety of intracellular proteins, including acetyl coenzyme A carboxylase (ACC) that is involved in fatty acid oxidation. Adenosine monophosphate–activated protein kinase increases glucose transport by stimulating the translocation of glucose transporter 4 (GLUT4) to the sarcolemma in the heart. Adiponectin exerts its effect through adiponectin receptors, which are predominantly expressed in the liver and skeletal muscle. It is unknown whether the cardiac expression of adiponectin and its receptors is changed in diabetic rats. In the present study, we investigated the protein expression of adiponectin and its receptors in streptozotocin (STZ)–induced diabetic rat hearts. We also explored whether the levels of AMPK, ACC, and GLUT4 will be altered with the changed adiponectin and its receptors in STZ diabetic rat hearts. Plasma and cardiac adiponectin levels were measured by radioimmunoassay. Plasma and cardiac interleukin 6 and plasma tumor necrosis factor α (TNF-α) were assayed by enzyme-linked immunosorbent assay. Cardiac adiponectin receptors, AMPK-α, ACC, GLUT4, and TNF-α were analyzed by Western blot in control and STZ diabetic rats. The plasma adiponectin level was decreased, but the cardiac protein expression of adiponectin receptor 1 was increased in diabetic rats. There was no difference in the cardiac adiponectin level and the cardiac adiponectin receptor 2 protein expression between control and diabetic rats. The phosphorylation of AMPK-α and protein expression of GLUT4 were decreased, but the phosphorylation of ACC was unchanged in diabetic rat hearts. Plasma and cardiac levels of interleukin 6 and TNF-α were increased in diabetic rats. In conclusion, STZ-induced diabetes up-regulates adiponectin receptors in the heart. Despite an increase in cardiac adiponectin receptor 1 expression, there is an increased cardiac inflammatory response and a decreased GLUT4 protein expression associated with a reduction in circulating adiponectin. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
9. N-acetylcysteine attenuates TNF-α-induced human vascular endothelial cell apoptosis and restores eNOS expression
- Author
-
Xia, Zhengyuan, Liu, Min, Wu, Yong, Sharma, Vijay, Luo, Tao, Ouyang, Jingping, and McNeill, John H.
- Subjects
- *
APOPTOSIS , *CELL death , *CYTOKINES , *GROWTH factors - Abstract
Abstract: The circulatory inflammatory cytokine tumor necrosis factor-α (TNF-α) is increased in pathological conditions, such as diabetes, which initiate or exacerbate vascular endothelial injury. Both nitric oxide (NO) and reactive oxygen species may play a dual role (i.e., inhibiting or promoting) in TNF-α-induced endothelial cell apoptosis. We investigated the effects of the antioxidant N-acetylcysteine on TNF-α-induced apoptosis in human vascular endothelial cell (cell line ECV304) apoptosis, NO production and lipid peroxidation. Cultured vascular endothelial cell (ECV304) were either not treated (control), or treated with TNF-α (40 ng/ml) alone or TNF-α in the presence of N-acetylcysteine at 30 mmol/l or 1 mmol/l, respectively, for 24 h. Cell viability was measured by MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) assay. Cell apoptosis was assessed by flow cytometry. TNF-α-induced endothelial cell apoptosis was associated with increased inducible NO synthase but reduced endothelial NO synthase (eNOS) protein expression. NO production and the levels of the lipid peroxidation product malondialdehyde were concomitantly increased. Treatment with NAC at 30 mmol/l restored eNOS expression and further increased NO production as compared to TNF-α alone, resulting in improved cell viability and reduced apoptosis. This was accompanied by increased superoxide dismutase activity, increased glutathione peroxidase production and reduced malondialdehyde levels. N-acetylcysteine at 1 mmol/l, however, did not have significant effects on TNF-α-induced endothelial cell apoptosis and cell viability despite it slightly enhanced glutathione peroxidase production. N-acetylcysteine attenuation of TNF-α-induced human vascular endothelial cell apoptosis is associated with the restoration of eNOS expression. [Copyright &y& Elsevier]
- Published
- 2006
- Full Text
- View/download PDF
10. Antioxidant N-acetylcysteine restores myocardial Mn-SOD activity and attenuates myocardial dysfunction in diabetic rats
- Author
-
Xia, Zhengyuan, Guo, Zhixin, Nagareddy, Prabhakara R., Yuen, Violet, Yeung, Eugene, and McNeill, John H.
- Subjects
- *
ANTIOXIDANTS , *DIABETES , *HEART diseases , *LABORATORY rats - Abstract
Abstract: Manganese-containing superoxide dismutase (Mn-SOD) plays a critical role in guarding against mitochondrial oxidative stress. Abnormal myocardial mitochondrial metabolism of reactive oxygen species plays an important role in the pathogenesis of diabetic cardiac dysfunction. We hypothesised that chronic treatment with N-acetylcysteine, an antioxidant and glutathione (GSH) precursor, would normalize hyperglycemia induced inactivation of Mn-SOD and attenuate myocardial dysfunction. Control and streptozotozin-induced diabetic rats were treated or untreated with N-acetylcysteine in drinking water for 8 weeks, initiated 1 week after streptozotozin injection. Myocardial performance was determined using the isolated perfused working heart preparation. Myocardial Mn-SOD activity, but not Mn-SOD protein expression, in diabetic rats was significantly reduced while levels of oxidative stress as determined by myocardial free 15-F2t-isoprostane were increased in diabetic rats and were normalized by N-acetylcysteine treatment. However, compensatory increases in myocardial Cu/Zn-SOD and GSH content were seen in diabetic rats accompanied by an increase in tissue antioxidant capacity as compared to control. N-acetylcysteine abolished the compensatory increase in myocardial Cu/Zn-SOD. The left ventricular developed pressure and rates of left ventricular pressure development and relaxation were decreased in diabetic rats as compared to control. These effects were attenuated, but not prevented by N-acetylcysteine treatment. N-acetylcysteine attenuation of diabetic myocardial dysfunction could be attributed to the restoration of myocardial Mn-SOD activity. [Copyright &y& Elsevier]
- Published
- 2006
- Full Text
- View/download PDF
11. The effect of N-acetylcysteine on cardiac contractility to dobutamine in rats with streptozotocin-induced diabetes
- Author
-
Cheng, Xing, Xia, Zhengyuan, Leo, Joyce M., and Pang, Catherine C.Y.
- Subjects
- *
DOBUTAMINE , *CATECHOLAMINES , *PEOPLE with diabetes , *MENTAL depression - Abstract
Abstract: We examined if myocardial depression at the acute phase of diabetes (3 weeks after injection of streptozotocin, 60 mg/kg i.v.) is due to activation of inducible nitric oxide synthase and production of peroxynitrite, and if treatment with N-acetylcysteine (1.2 g/day/kg for 3 weeks, antioxidant) improves cardiac function. Four groups of rats were used: control, N-acetylcysteine-treated control, diabetic and N-acetylcysteine-treated diabetic. Pentobarbital-anaesthetized diabetic rats, relative to the controls, had reduced left ventricular contractility to dobutamine (1–57 μg/min/kg). The diabetic rats also had increased myocardial levels of thiobarbituric acid reactive substances, immunostaining of inducible nitric oxide synthase and nitrotyrosine, and similar baseline 15-F2t-isoprostane. N-acetylcysteine did not affect responses in the control rats; but increased cardiac contractility to dobutamine, reduced myocardial immunostaining of inducible nitric oxide synthase and nitrotyrosine and level of 15-F2t-isoprostane, and increased cardiac contractility to dobutamine in the diabetic rats. Antioxidant supplementation in diabetes reduces oxidative stress and improves cardiac function. [Copyright &y& Elsevier]
- Published
- 2005
- Full Text
- View/download PDF
12. Gut Microbiome Fermentation Determines the Efficacy of Exercise for Diabetes Prevention.
- Author
-
Liu, Yan, Wang, Yao, Ni, Yueqiong, Cheung, Cynthia K.Y., Lam, Karen S.L., Wang, Yu, Xia, Zhengyuan, Ye, Dewei, Guo, Jiao, Tse, Michael Andrew, Panagiotou, Gianni, and Xu, Aimin
- Abstract
Exercise is an effective strategy for diabetes management but is limited by the phenomenon of exercise resistance (i.e., the lack of or the adverse response to exercise on metabolic health). Here, in 39 medication-naive men with prediabetes, we found that exercise-induced alterations in the gut microbiota correlated closely with improvements in glucose homeostasis and insulin sensitivity (clinicaltrials.gov entry NCT03240978). The microbiome of responders exhibited an enhanced capacity for biosynthesis of short-chain fatty acids and catabolism of branched-chain amino acids, whereas those of non-responders were characterized by increased production of metabolically detrimental compounds. Fecal microbial transplantation from responders, but not non-responders, mimicked the effects of exercise on alleviation of insulin resistance in obese mice. Furthermore, a machine-learning algorithm integrating baseline microbial signatures accurately predicted personalized glycemic response to exercise in an additional 30 subjects. These findings raise the possibility of maximizing the benefits of exercise by targeting the gut microbiota. • A high variability in glycemic response to exercise in subjects with prediabetes exists • Responders and non-responders exhibit differential alterations of the gut microbiota • Gut microbiota from responders confers the metabolic benefits of exercise in mice • Baseline microbiome features accurately predict personalized exercise responses Liu et al. identify the gut microbiota as an important determinant in the responsiveness of individuals with prediabetes to exercise for the improvement of glucose metabolism and insulin sensitivity. These findings may help in the implementation of a personalized lifestyle intervention for diabetes prevention. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
13. Antioxidant intervention before and during myocardial ischemia may exacerbate post-ischemic myocardial dysfunction: Relationship with endothelin-1 production.
- Author
-
Nie, Ruqiong, Zhong, Xingwu, and Xia, Zhengyuan
- Published
- 2008
- Full Text
- View/download PDF
14. ω-Alkynyl arachidonic acid promotes anti-inflammatory macrophage M2 polarization against acute myocardial infarction via regulating the cross-talk between PKM2, HIF-1α and iNOS.
- Author
-
Cheng, Yuanyuan, Feng, Yibin, Xia, Zhengyuan, Li, Xuechen, and Rong, Jianhui
- Subjects
- *
ARACHIDONIC acid , *MACROPHAGE activation , *POLARIZATION (Electrochemistry) , *BIOLOGICAL crosstalk , *PHYSIOLOGY ,MYOCARDIAL infarction diagnosis - Abstract
Macrophage polarization determines the timing for the switch from the inflammation phase to the inflammation resolution phase after acute myocardial infarction. The aim of the present study was to investigate whether ω-alkynyl arachidonic acid could mitigate the inflammatory lipid mediators in the regulation of macrophage phenotypes and functions with a special regard to myocardial infarction. We initially discovered that ω-alkynyl arachidonic acid selectively suppressed the up-regulation of inducible nitric oxide synthase (iNOS) over cyclooxygenase-2 (COX-2) in LPS-stimulated macrophages. ω-Alkynyl arachidonic acid also reduced the expression of macrophage M1 biomarkers (e.g., TNF-α, CXCL10, iNOS and IL-6) but increased the expression of macrophage M2 biomarkers (e.g., IL-10 and arginase-1) in LPS-stimulated macrophages. Moreover, ω-alkynyl arachidonic acid markedly enhanced the phagocytotic activity of macrophages against fluorescently-labeled beads or apoptotic H9c2 cardiac cells. We further investigated the in vivo cardioprotective activities of ω-alkynyl arachidonic acid in a mouse model of myocardial infarction. ω-Alkynyl arachidonic acid indeed reduced infarct size, cardiac damage and the leakage of myocardial enzymes CK-MB. Mechanistic studies revealed that ω-alkynyl arachidonic acid suppressed the overexpression and nuclear translocation of glycolytic enzyme PKM2 in LPS-stimulated macrophages. Furthermore, co-immunoprecipitation assay suggested that ω-alkynyl arachidonic acid disrupted the interaction between PKM2 and HIF-1α. Consequently, ω-alkynyl arachidonic acid diminished HIF-1α binding to the HRE sequence in iNOS promoter in response to LPS stimulation. Collectively, ω-alkynyl arachidonic acid may promote the anti-inflammatory M2 polarization of macrophages in acute myocardial infarction via regulating the cross-talk between PKM2, HIF-1α and iNOS. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
15. A mechanism for effects of nitric oxide donors on LPS-induced pulmonary oedema
- Author
-
Xia, Zhongyuan, Xia, Zhengyuan, and Chen, Xiangdong
- Published
- 2007
- Full Text
- View/download PDF
16. Exploring the therapeutic potential of tetrahydrobiopterin for heart failure with preserved ejection fraction: A path forward.
- Author
-
Xia, Weiyi, Zhang, Miao, Liu, Chang, Wang, Sheng, Xu, Aimin, Xia, Zhengyuan, Pang, Lei, and Cai, Yin
- Subjects
- *
TETRAHYDROBIOPTERIN , *VENTRICULAR ejection fraction , *HEART failure , *GUANYLATE cyclase , *ANTIOXIDANTS , *CARDIOVASCULAR diseases , *NEPRILYSIN , *SODIUM-glucose cotransporters - Abstract
A large number of patients are affected by classical heart failure (HF) symptomatology with preserved ejection fraction (HFpEF) and multiorgan syndrome. Due to high morbidity and mortality rate, hospitalization and mortality remain serious socioeconomic problems, while the lack of effective pharmacological or device treatment means that HFpEF presents a major unmet medical need. Evidence from clinical and basic studies demonstrates that systemic inflammation, increased oxidative stress, and impaired mitochondrial function are the common pathological mechanisms in HFpEF. Tetrahydrobiopterin (BH4), beyond being an endogenous co-factor for catalyzing the conversion of some essential biomolecules, has the capacity to prevent systemic inflammation, enhance antioxidant resistance, and modulate mitochondrial energy production. Therefore, BH4 has emerged in the last decade as a promising agent to prevent or reverse the progression of disorders such as cardiovascular disease. In this review, we cover the clinical progress and limitations of using downstream targets of nitric oxide (NO) through NO donors, soluble guanylate cyclase activators, phosphodiesterase inhibitors, and sodium-glucose co-transporter 2 inhibitors in treating cardiovascular diseases, including HFpEF. We discuss the use of BH4 in association with HFpEF, providing new evidence for its potential use as a pharmacological option for treating HFpEF. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. Perioperative dexmedetomidine and 5-year survival in patients undergoing cardiac surgery.
- Author
-
Peng, Ke, Shen, Yue-ping, Ying, Yao-yu, Kiaii, Bob, Rodriguez, Victor, Boyd, Douglas, Applegate II, Richard L., Lubarsky, David A., Zhang, Zugui, Xia, Zhengyuan, Feng, Xiao-mei, Yang, Jian-ping, Liu, Hong, Ji, Fu-hai, and Applegate, Richard L 2nd
- Subjects
- *
CARDIOPULMONARY bypass , *CARDIAC surgery , *CORONARY artery bypass , *DEXMEDETOMIDINE , *OPERATIVE surgery , *CARDIAC patients , *PERIOPERATIVE care , *RESEARCH , *RESEARCH methodology , *RETROSPECTIVE studies , *MEDICAL cooperation , *EVALUATION research , *IMIDAZOLES , *TREATMENT effectiveness , *COMPARATIVE studies , *SURVIVAL analysis (Biometry) , *LONGITUDINAL method ,PREVENTION of surgical complications - Abstract
Background: Dexmedetomidine sedation has been associated with favourable outcomes after surgery. We aimed to assess whether perioperative dexmedetomidine use is associated with improved survival after cardiac surgery.Methods: This retrospective cohort study included 2068 patients undergoing on-pump coronary artery bypass grafting and/or valve surgery. Among them, 1029 patients received dexmedetomidine, and 1039 patients did not. Intravenous dexmedetomidine infusion of 0.007 μg kg-1 min-1 was initiated before or immediately after cardiopulmonary bypass and lasted for < 24 h. The primary outcome was 5-year survival after cardiac surgery. The propensity scores matching (PSM), inverse probability of treatment weighting (IPTW), and overlap weighting approaches were used to minimise bias. Survival analyses were performed with Cox proportional-hazard models.Results: The median age was 63 yr old and the male to female ratio was 71:29 in both groups. Baseline covariates were balanced between groups after adjustment using PSM, IPTW, or overlap weighting. Patients receiving dexmedetomidine in cardiac surgical procedures had higher survival during postoperative 5 yr in unadjusted analysis (hazard ratio [HR]=0.63; 95% confidence interval [CI], 0.51-0.78; P<0.001), and after adjustment with PSM (HR=0.63; 95% CI, 0.45-0.89; P=0.009), IPTW (HR=0.70; 95% CI, 0.51-0.95; P=0.023), or overlap weighting (HR=0.67; 95% CI, 0.51-0.89; P=0.006). The 5-yr mortality rate after cardiac surgery was 13% and 20% in the dexmedetomidine and non-dexmedetomidine groups, respectively (PSM adjusted odds ratio=0.61; 95% CI, 0.42-0.89; P=0.010).Conclusion: Perioperative dexmedetomidine infusion was associated with improved 5-yr survival in patients undergoing cardiac surgery. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
18. The mechanism of CaMK2α-MCU-mitochondrial oxidative stress in bupivacaine-induced neurotoxicity.
- Author
-
Liu, Zhongjie, Zhao, Wei, Yuan, Pengfei, Zhu, Pian, Fan, Keke, Xia, Zhengyuan, and Xu, Shiyuan
- Subjects
- *
NEUROTOXICOLOGY , *CREB protein , *OXIDATIVE stress , *SPINAL infusions , *LOCAL anesthetics , *CARRIER proteins - Abstract
Ca2+/calmodulin dependent protein kinase2α (CaMK2α) is a serine/threonine protein kinase in neurons and leads to neuronal injury when it is activated abnormally. Bupivacaine, a local anesthetic commonly used in regional nerve block, could induce neurotoxicity via apoptotic injury. Whether or not CaMK2α is involved in bupivacaine-induced neurotoxicity and it is regulated remains unclear. In this study, bupivacaine was administered for intrathecal injection in C57BL/6 mice for building vivo injury model and was used to culture human neuroblastoma (SH-SY5Y) cells for building vitro injury model. The results showed that bupivacaine induced mitochondrial oxidative stress and neurons apoptotic injury, promoted phosphorylation of CaMK2α and cAMP-response element binding protein (CREB), and elevated mitochondrial Ca2+ uniporter (MCU) expression. Furthermore, it induced CaMK2α phosphorylation at Thr286 which phosphorylated CREB at Ser133 and up-regulated MCU transcriptional expression. Inhibition of CaMK2α-MCU signaling with knock-down of CaMK2α and MCU or with inhibitors (KN93 and Ru360) significantly mitigated bupivacaine-induced neurotoxic injury. Over-expression of CaMK2α significantly enhanced above oxidative injury. Activated MCU with agonist (spermine) reversed protective effect of siCaMK2α on bupivacaine-induced mitochondrial oxidative stress. Our data revealed that CaMK2α-MCU-mitochondrial oxidative stress pathway is a major mechanism whereby bupivacaine induces neurotoxicity and inhibition of above signaling could be a therapeutic strategy in the treatment of bupivacaine-induced neurotoxicity. Image 1 • A regulation mechanism of Ca2+/calmodulin dependent protein kinase2α (CaMK2α) and mitochondrial oxidative damage is proposed. • The mechanism relies on CaMK2α/cAMP-response element binding protein (CREB) signaling activating to regulate mitochondrial Ca2+ uniporter (MCU) expression in bupivacaine-induced mitochondrial oxidative damage. • The mechanism of CaMK2α-MCU signaling in bupivacaine-induced neurotoxicity is determined. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
19. EP4 emerges as a novel regulator of bile acid synthesis and its activation protects against hypercholesterolemia.
- Author
-
Ying, Fan, Cai, Yin, Wong, Hoi Kin, Chen, Xin Yi, Huang, Ianto Bosheng, Vanhoutte, Paul M., Xia, Zhengyuan, Xu, Aimin, and Tang, Eva Hoi Ching
- Subjects
- *
BILE acids , *HYPERCHOLESTEREMIA , *PROSTAGLANDIN receptors , *EXTRACELLULAR signal-regulated kinases , *PHOSPHORYLATION - Abstract
Prostaglandin E receptor subtype 4 (EP4) knockout mice develops spontaneous hypercholesterolemia but the detailed mechanisms by which EP4 affects cholesterol homeostasis remains unexplored. We sought to determine the cause of hypercholesterolemia in EP4 knockout mice, focusing on the role of EP4 in regulating the synthesis and elimination of cholesterol. Deficiency of EP4 significantly decreased total bile acid levels in the liver by 26.2% and the fecal bile acid content by 27.6% as compared to wild type littermates, indicating that the absence of EP4 decreased hepatic bile acid synthesis and their subsequent excretion in stools. EP4 deficiency negatively regulate bile acid synthesis through repression of phosphorylated extracellular signal-regulated kinase 1/2 (ERK)-mediated cholesterol 7α-hydroxylase (CYP7A1) expression and that the hypercholesterolemia in EP4 knockout mice is due to a defect in cholesterol conversion into bile acids. Deficiency of EP4 also increased de novo cholesterol synthesis and altered cholesterol fluxes in and out of the liver. Treating high fat diet-challenged mice with the pharmacological EP4 agonist, CAY10580 (200 μg/kg body weight/day i . p ) for three weeks effectively prevented diet-induced hypercholesterolemia, enhanced endogenous bile acid synthesis and their fecal excretion. In summary, EP4 plays a critical role in maintaining cholesterol homeostasis by regulating the synthesis and elimination of bile acids. Activation of EP4 serves as an effective novel strategy to promote cholesterol disposal in the forms of bile acids in order to lower plasma cholesterol levels. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
20. SERPINB1 ameliorates acute lung injury in liver transplantation through ERK1/2-mediated STAT3-dependent HO-1 induction.
- Author
-
Yao, Weifeng, Luo, Gangjian, Li, Xiang, Chen, Chaojin, Yuan, Dongdong, Chi, Xinjin, Hei, Ziqing, Li, Haobo, and Xia, Zhengyuan
- Subjects
- *
SERPINS , *LUNG injuries , *LIVER transplantation , *HEME oxygenase , *STAT proteins - Abstract
Background Postoperative acute lung injury (ALI) is a severe complication after liver transplantation, which severely affects postoperative patients’ survival. The underlying mechanism is largely unknown and effective treatment limited. We explored the role of serpin protease inhibitor B1 (SERPINB1), a potent inhibitor of neutrophil serine proteases, in ALI in liver transplantation and its interplay with signal transducer and activator of transcription 3 (STAT3) and heme oxygenase-1 (HO-1). Methods Sprague-Dawley rats underwent orthotopic autologous liver transplantation (OALT) were treated with recombinant SB1 (rSB1) in the absence or presence of STAT3 specific inhibitor, WP1066. Then SB1-siRNA was used to knockdown endogenous SERPINB1. Also, alveolar epithelial cells RLE-6TN and BEAS-2B were exposed to TNF-α without or with SERPINB1 and the roles of STAT3 and HO-1 were examined by respective gene knockdown. Finally, rats were treated with ERK1/2 inhibitor U0126, p38 MAPK inhibitor SB20358, or JNK inhibitor SP600125 after rSB1 pretreatment and then subjected to OALT. Results OALT resulted in increased pulmonary inflammation and oxidative stress, accompanied by severe lung injury that was coincident with increased pulmonary SERPINB1, HO-1, and STAT3. SERPINB1 gene knockdown increased post-OALT lung injury and pulmonary inflammation. rSB1 administration dose-dependently reduced post-OALT lung injury and decreased pulmonary inflammation and oxidative stress with concomitant enhanced HO-1 and STAT3 protein expression. These protective effects of SERPINB1 were abolished by STAT3 inhibition. Similarly, in RLE-6TN cells and BEAS-2B cells, TNF-α induced cell injury and increased HO-1 and STAT3. SERPINB1 further increased HO-1 and STAT3 protein expression and attenuated TNF-α-induced cellular oxidative stress, apoptotic cells, and mitochondria damage, which were cancelled by STAT3 or HO-1 gene knockdown. Furthermore, these SERPINB1-mediated STAT3/HO-1 activation and pulmonary protective effects were abolished by inhibition of ERK1/2 but not p38 MAPK or JNK. Conclusions SERPINB1 decreased inflammation, ameliorated oxidative stress in the lung, and attenuated ALI in rats with OALT by activating HO-1 and it does so through STAT3 and it does so by activating ERK1/2. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
21. Astrocyte contributes to pain development via MMP2-JNK1/2 signaling in a mouse model of complex regional pain syndrome.
- Author
-
Tian, Guogang, Luo, Xin, Tang, Chaoliang, Cheng, Xiang, Chung, Sookja Kim, Xia, Zhengyuan, Cheung, Chi Wai, and Guo, Qulian
- Subjects
- *
COMPLEX regional pain syndromes , *NEUROGLIA , *MICROGLIA , *ASTROCYTES , *ALLODYNIA - Abstract
Background The activation of spinal glial cells (astrocyte and microglia) is reported in patient with complex regional pain syndrome (CRPS). However, the roles of spinal glial activities in the pathophysiology of CRPS are unclear. Here, we explored the roles of spinal astrocyte and microglia and the molecular mechanisms underlying CRPS using a mouse model of chronic post-ischemia pain (CPIP). Results CPIP injury increased the level of glial fibrillary acidic protein (GFAP, reactive astrocyte biomarker), but had no significant impact on ionized calcium binding adaptor molecule 1 (IBA1, reactive microglia biomarker), in the ipsilateral dorsal horn on post-injury day (PID) 3 when the pain threshold started to reduce significantly. Astrocytic inhibition with fluorocitrate but not microglial inhibition with minocycline attenuated the development of allodynia in CPIP-injured mice, which was concomitant with increased spinal levels of phosphorylated c-jun N-terminal kinase 1/2 (pJNK1/2) on PID 3. Furthermore, the intrathecal administration of SP600125 (JNK inhibitor) prevented the development of allodynia in CPIP-injured mice. Double immunofluorescence staining showed that pJNK1/2 was mainly co-localized with GFAP. Subsequently, increased levels of pJNK1/2 were reversed by intrathecal fluorocitrate. Furthermore, the level of spinal matrix metalloproteinase-2 (MMP2) was increased and mainly expressed in NeuN (neuron biomarker) on PID 3 in the CPIP-injured mice, while intrathecal APR 100 (MMP2 inhibitor) delayed the development of allodynia and decreased spinal levels of GFAP and pJNK1/2 on PID 3. Conclusion This study shows that activation of astrocyte MMP2/JNK1/2 signaling pathway contributes to the pathogenesis of pain hypersensitivity in the CPIP model. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
22. Remote ischemic postconditioning protects against renal ischemia/reperfusion injury by activation of T-LAK-cell-originated protein kinase (TOPK)/PTEN/Akt signaling pathway mediated anti-oxidation and anti-inflammation.
- Author
-
Gao, Sumin, Zhu, Yi, Li, Haobo, Xia, Zhengyuan, Wu, Qingping, Yao, Shanglong, Wang, Tingting, and Yuan, Shiying
- Subjects
- *
REPERFUSION injury , *PROTEIN kinases , *CELLULAR signal transduction , *ANTI-inflammatory agents , *ANTIOXIDANTS , *ANIMAL models in research - Abstract
Background Recent clinical and animal studies suggested that remote limb ischemic postconditioning (RIPostC) can invoke potent cardioprotection or neuroprotection. However, the effect and mechanism of RIPostC against renal ischemia/reperfusion injury (IRI) are poorly understood. T-LAK-cell-originated protein kinase (TOPK) is crucial for the proliferation and migration of tumor cells. However, the function of TOPK and the molecular mechanism underlying renal protection remain unknown. Therefore, this study aimed to evaluate the role of TOPK in renoprotection induced by RIPostC. Materials and Methods The renal IRI model was induced by left renal pedicle clamping for 45 min followed by 24 h reperfusion and right nephrectomy. All mice were intraperitoneally injected with vehicle, TOPK inhibitor HI-TOPK-032 or Akt inhibitor LY294002. After 24 h reperfusion, renal histology, function, and inflammatory cytokines and oxidative stress were assessed. The proteins were measured by Western blotting. Results The results showed that RIPostC significantly protected the kidneys against IRI. The protective effects were accompanied by the attenuation of renal dysfunction, tubular damage, inflammation and oxidative stress. In addition, RIPostC increased the phosphorylation of TOPK, PTEN, Akt, GSK3β and the nuclear translocation of Nrf2 and decreased the nuclear translocation of NF-κB. However, all of the above renoprotective effects of RIPostC were eliminated either by the inhibition of TOPK or Akt with HI-TOPK-032 or LY294002. Conclusions The current data reveal that RIPostC protects against renal IRI via activation of TOPK/PTEN/Akt signaling pathway mediated anti-oxidation and anti-inflammation. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
23. Diabetes blocks the cardioprotective effects of sevoflurane postconditioning by impairing Nrf2/Brg1/HO-1 signaling.
- Author
-
Gao, Sumin, Yang, Zhengchao, Shi, Ruili, Xu, Dan, Li, Haobo, Xia, Zhengyuan, Wu, Qing-ping, Yao, Shanglong, Wang, Tingting, and Yuan, Shiying
- Subjects
- *
CARDIOTONIC agents , *TREATMENT of diabetes , *SEVOFLURANE , *HEME oxygenase , *HEART cells , *OXIDATIVE stress , *OXIDANT status , *THERAPEUTICS - Abstract
Sevofluane postconditioning (SPostC) protects heart against ischemia/reperfusion injury. However, SPostC cardioprotection is lost in diabetes whose cardiac heme oxygenase-1 (HO-1) is reduced. Brahma-related gene 1 (Brg1) facilitates nuclear factor-erythroid-2-related factor-2 (Nrf2) to activate HO-1 to increase myocardial antioxidant capacity in response to oxidative stress. However, cardiac Brg1 is reduced in diabetes. We hypothesized that SPostC confers cardioprotection by activating HO-1 through Nrf2/Brg1 and that impaired Nrf2/Brg1/HO-1 in diabetes is responsible for the loss of SPostC. Control and streptozotocin-induced diabetic mice were subjected to 45 min coronary artery occlusion followed by 2 h reperfusion with or without SPostC achieved by exposing the mice to 2% sevoflurane for 15 min at the onset of reperfusion. In in vitro study, H9c2 cells were exposed to normal or high glucose and subjected to 3 h hypoxia followed by 6 h reoxygenation. Diabetic mice displayed larger post-ischemic infarct size, severer cardiomyocytes apoptosis, and increased oxidative stress concomitant with reduced HO-1, nuclear Nrf2 and Brg1 protein expression. These changes were prevented/reversed by SPostC in control but not in diabetic mice, and these beneficial effects of SPostC were abolished by HO-1 inhibition. In H9c2 cells exposed to normal glucose but not high glucose, SPostC significantly attenuated hypoxia/reoxygenation-induced cellular injury and oxidative stress with increased HO-1 and nuclear Nrf2. These SPostC beneficial effects were canceled by HO-1 inhibition. In conclusion, SPostC protects against myocardial ischemia/reperfusion injury through activation of Nrf2/Brg1/HO-1 signaling and impairment of this signaling may be responsible for the loss of SPostC cardioprotection in diabetes. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
24. Adiponectin ameliorates hyperglycemia-induced cardiac hypertrophy and dysfunction by concomitantly activating Nrf2 and Brg1.
- Author
-
Li, Haobo, Yao, Weifeng, Irwin, Michael G., Wang, Tingting, Wang, Shuang, Zhang, Liangqing, and Xia, Zhengyuan
- Subjects
- *
ADIPONECTIN , *HYPERGLYCEMIA , *CARDIAC hypertrophy , *HEME oxygenase , *OXIDATIVE stress , *DIABETES complications - Abstract
Hyperglycemia-induced oxidative stress is implicated in the development of cardiomyopathy in diabetes that is associated with reduced adiponectin (APN) and heme oxygenase-1 (HO-1). Brahma-related gene 1 (Brg1) assists nuclear factor-erythroid-2-related factor-2 (Nrf2) to activate HO-1 to increase myocardial antioxidant capacity in response to oxidative stress. We hypothesized that reduced adiponectin (APN) impairs HO-1 induction which contributes to the development of diabetic cardiomyopathy, and that supplementation of APN may ameliorate diabetic cardiomyopathy by activating HO-1 through Nrf2 and Brg1 in diabetes. Control (C) and streptozotocin-induced diabetic (D) rats were untreated or treated with APN adenovirus (1×10 9 pfu) 3 weeks after diabetes induction and examined and terminated 1 week afterward. Rat left ventricular functions were assessed by a pressure–volume conductance system, before the rat hearts were removed to perform histological and biochemical assays. Four weeks after diabetes induction, D rats developed cardiac hypertrophy evidenced as increased ratio of heart weight to body weight, elevated myocardial collagen I content, and larger cardiomyocyte cross-sectional area (all P <0.05 vs C). Diabetes elevated cardiac oxidative stress (increased 15-F 2t -isoprostane, 4-hydroxynonenal generation, 8-hydroxy-2′-deoxyguanosine, and superoxide anion generation), increased myocardial apoptosis, and impaired cardiac function (all P <0.05 vs C). In D rats, myocardial HO-1 mRNA and protein expression were reduced which was associated with reduced Brg1 and nuclear Nrf2 protein expression. All these changes were either attenuated or prevented by APN. In primarily cultured cardiomyocytes (CMs) isolated from D rats or in the embryonic rat cardiomyocytes cell line H9C2 cells incubated with high glucose (HG, 25 mM), supplementation of recombined globular APN (gAd, 2 μg/mL) reversed HG-induced reductions of HO-1, Brg1, and nuclear Nrf2 protein expression and attenuated cellular oxidative stress, myocyte size, and apoptotic cells. Inhibition of HO-1 by ZnPP (10 μM) or small interfering RNA (siRNA) canceled all the above gAd beneficial effects. Moreover, inhibition of Nrf2 (either by the Nrf2 inhibitor luteolin or siRNA) or Brg1 (by siRNA) canceled gAd-induced HO-1 induction and cellular protection in CMs and in H9C2 cells incubated with HG. In summary, our present study demonstrated that APN reduced cardiac oxidative stress, ameliorated cardiomyocyte hypertrophy, and prevented left ventricular dysfunction in diabetes by concomitantly activating Nrf2 and Brg1 to facilitate HO-1 induction. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
25. Endogenous expression pattern of resolvin D1 in a rat model of self-resolution of lipopolysaccharide-induced acute respiratory distress syndrome and inflammation.
- Author
-
Sun, Wei, Wang, Zai-ping, Gui, Ping, Xia, Weiyi, Xia, Zhengyuan, Zhang, Xing-cai, Deng, Qing-zhu, Xuan, Wei, Marie, Christelle, Wang, Lin-lin, Wu, Qing-ping, Wang, Tingting, and Lin, Yun
- Subjects
- *
ADULT respiratory distress syndrome treatment , *PHYSIOLOGICAL effects of lipopolysaccharides , *GENE expression , *INFLAMMATION , *DOCOSAHEXAENOIC acid , *LABORATORY rats , *THERAPEUTICS - Abstract
Resolvin D1 (RvD1), an endogenous lipid mediator derived from docosahexaenoic acid, has been reported to promote a biphasic activity in anti-inflammatory response and regulate inflammatory resolution. The present study aimed to determine the endogenous expression pattern of RvD1 in a rat model of self-resolution of lipopolysaccharide (LPS)-induced acute respiratory distress syndrome (ARDS) and inflammation. The ARDS model was induced by administrating LPS (2 mg/kg) via tracheotomy in 138 male Sprague–Dawley rats. At specified time points, lung injury and inflammation were respectively assessed by lung histology and analysis of bronchoalveolar lavage fluid and cytokine levels. The expression of endogenous RvD1 was detected by high performance liquid chromatography and tandem mass spectrometry. The results showed that histological lung injury peaked between 6 h (LPS6h) and day 3, followed by recovery over 4–10 days after LPS administration. Lung tissue polymorph nuclear cell (PMN) was significantly increased at LPS6h, and peaked between 6 h to day 2. The levels of interleukin (IL)-6 and IL-10 were significantly increased at LPS6h and remained higher over day 10 as compared to baseline. Intriguingly, the endogenous RvD1 expression was decreased gradually during the first 3 days, followed by almost completely recovery over days 9–10. The finding indicated that endogenous RvD1 underwent a decrease in expression followed by gradual increase that was basically coincident with the lung injury recovery in a rat model of self-resolution LPS-induced ARDS and inflammation. Our results may help define the optimal therapeutic window for endogenous RvD1 to prevent or treat LPS-induced ARDS and inflammation. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
26. High dose remifentanil increases myocardial oxidative stress and compromises remifentanil infarct-sparing effects in rats.
- Author
-
Mei, Bin, Wang, Tingting, Wang, Yuan, Xia, Zhengyuan, Irwin, Michael G., and Wong, Gordon T.C.
- Subjects
- *
PIPERIDINE , *OXIDATIVE stress , *CARDIOMYOPATHIES , *MYOCARDIAL infarction , *DRUG dosage , *LABORATORY rats , *THERAPEUTICS - Abstract
Abstract: Chronic administration of high dose opioids such as morphine is known to create intracellular oxidative stress via an opioid receptor dependent mechanism and this can interfere with cellular function. This study aimed at examining whether such changes can occur following short term exposure to high concentration of remifentanil, a potent short acting opioid. We conducted a experimental study using rat myocardium and systematically quantified tissue levels of superoxide anions, malondialdehyde (MDA) and nitrotyrosine following exposure to increasing duration (15min, 1 or 2h) or escalating doses of remifentanil (1μg, 5μg, 10μg or 20μg/kg/min). Concurrently the susceptibility of the heart to ischaemia reperfusion injury was assessed under the similar conditions. For any given duration of remifentanil infusion, there was increasing superoxide anions generated as the dose of remifentanil was increased. MDA concentrations were significantly increased when the animal was exposed to 10μg/kg/min for 2h or 20μg/kg/min for any duration. There was a trend towards an increased nitrotyrosine concentration with increasing dose of remifentanil, becoming significant when the dose was 20μg/kg/min. The infarct limiting ability of remifentanil was compromised when the dihydroethidium fluorescence positive cell percentage exceeded 50%, MDA concentration greater than 2nmol/mg of protein and nitrotyrosine content exceeding 1.5μg/mg of protein. Short term high dose opioid exposure can induce oxidative changes seen previously only with chronic opioid use and this high oxidative stress environment corrupts the heart's sensitivity to be preconditioned by opioids. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
27. N-Acetylcysteine and allopurinol up-regulated the Jak/STAT3 and PI3K/Akt pathways via adiponectin and attenuated myocardial postischemic injury in diabetes.
- Author
-
Wang, Tingting, Mao, Xiaowen, Li, Haobo, Qiao, Shigang, Xu, Aimin, Wang, Junwen, Lei, Shaoqing, Liu, Zipeng, Ng, Kwok F.J., Wong, Gordon T., Vanhoutte, Paul M., Irwin, Michael G., and Xia, Zhengyuan
- Subjects
- *
ACETYLCYSTEINE , *ALLOPURINOL , *PROTEIN kinase B , *ADIPONECTIN , *MYOCARDIAL infarction , *ISCHEMIA , *DIABETES , *CELLULAR signal transduction - Abstract
Abstract: N-Acetylcysteine (NAC) and allopurinol (ALP) synergistically reduce myocardial ischemia reperfusion (MI/R) injury in diabetes. However, the mechanism is unclear. We postulated that NAC and ALP attenuated diabetic MI/R injury by up-regulating phosphatidylinositol 3-kinase/Akt (PI3K/Akt) and Janus kinase 2/signal transducer and activator of transcription-3 (JAK2/STAT3) pathways subsequent to adiponectin (APN) activation. Control (C) or streptozotocin-induced diabetic rats (D) were untreated or treated with NAC and ALP followed by MI/R. D rats displayed larger infarct size accompanied by decreased phosphorylation of Akt, STAT3 and decreased cardiac nitric oxide (NO) and APN levels. NAC and ALP decreased MI/R injury in D rats, enhanced phosphorylation of Akt and STAT3, and increased NO and APN. High glucose and hypoxia/reoxygenation exposure induced cell death and Akt and STAT3 inactivation in cultured cardiomyocytes, which were prevented by NAC and ALP. The PI3K inhibitor wortmannin and Jak2 inhibitor AG490 abolished the protection of NAC and ALP. Similarly, APN restored posthypoxic Akt and STAT3 activation and decreased cell death in cardiomyocytes. Gene silencing with AdipoR2 siRNA or STAT3 siRNA but not AdipoR1 siRNA abolished the protection of NAC and ALP. In conclusion, NAC and ALP prevented diabetic MI/R injury through PI3K/Akt and Jak2/STAT3 and cardiac APN may serve as a mediator via AdipoR2 in this process. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
28. Cardioprotection from remote preconditioning involves spinal opioid receptor activation
- Author
-
Wong, Gordon Tin Chun, Lu, Yao, Mei, Bin, Xia, Zhengyuan, and Irwin, Michael G.
- Subjects
- *
PREVENTION of heart diseases , *OPIOID receptors , *ISCHEMIA , *CENTRAL nervous system , *SPINAL cord , *ANESTHESIA in cardiology - Abstract
Abstract: Aims: Remote preconditioning is a powerful and potentially clinically viable mode of cardioprotection. The mechanisms underlying its transmission process have not been extensively studied. The aim of this study was to test the hypothesis that spinal opioid receptors are involved with signal transmission of remote cardiac preconditioning. Main methods: Two established models of remote preconditioning were used, one using intermittent ischaemia of the lower limb (remote ischaemic preconditioning, RIPC) and the other by stimulation of cutaneous pain fibres via an abdominal incision (remote preconditioning of trauma, RPOT). Classic ischaemic preconditioning (IPC) was used as positive control. Selective blockade of spinal opioid receptors was achieved through intrathecal injection of naloxone methiodide, a compound not known to cross the blood–brain barrier. Key findings: The prior introduction of naloxone methiodide abolished the cardioprotective effects of RIPC, RPOT but not IPC, as assessed by infarct size as a percentage of area at risk following 30min of ischaemia and 120min reperfusion. Of the specific receptor antagonists, only that specific for the mu receptor subtype, and not delta or kappa receptor, block the protective response. Significance: These results suggest that the central nervous system at the spinal cord level is involved with the relaying of signals between the afferent and efferent arms of remote preconditioning. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
29. Alternative use of isoflurane and propofol confers superior cardioprotection than using one of them alone in a dog model of cardiopulmonary bypass
- Author
-
Li, Tao, Wu, Wei, You, Zhen, Zhou, Ronghua, Li, Qian, Zhu, Da, Li, Hui, Xiang, Xujin, Irwin, Michael G., Xia, Zhengyuan, and Liu, Jin
- Subjects
- *
ISOFLURANE , *PROPOFOL , *CARDIOPULMONARY bypass , *CORONARY disease , *REPERFUSION injury , *REGRESSION analysis , *LABORATORY dogs - Abstract
Abstract: Our previous clinical study reported that isoflurane preconditioning and high-dose propofol posttreatment attenuated myocardial ischemia/reperfusion injury of patients in surgery with cardiopulmonary bypass (CPB). This study was designed to confirm this cardiac protection by use of a dog CPB model and to elucidate the related mechanism. Adult mongrel male dogs undergoing standard CPB were assigned into 4 groups: Sham group, Propofol group, Isoflurane (Iso) group and isoflurane in combination of propofol (pre-Iso+P) group. After induction, anesthesia was maintained with propofol (Propofol group), isoflurane (Iso group) or isoflurane preconditioning in combination with propofol posttreatment (pre-Iso+P group). After 2h cardiac arrest and CPB, aortic cross-clamping was released to allow 2h reperfusion. The results demonstrated that joint use of isoflurane and propofol facilitated cardiac functional recovery, improved myocardial oxygen utilization and decreased cardiac enzyme release. Also, the oxidative damage caused by ischemia/reperfusion injury was remarkably attenuated. Linear regression analysis showed that cardiac function performance and oxidative stress status were inversely correlated, indicating the improved cardiac function was in closed association with the attenuation of oxidative stress. In addition, the cardiac oxygen consumption (VO2) was found to be significantly associated with the above cardiac function and oxidative stress parameters, suggesting VO2 was predictive for the levels of cardiac damage and oxidative stress. Therefore, we conclude that alternative use of isoflurane and propofol confers superior cardioprotection against postischemic myocardial injury and dysfunction, and this protection was probably mediated by attenuation of cardiac oxidative damage. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
30. Ischaemic post-conditioning protects lung from ischaemia-reperfusion injury by up-regulation of haeme oxygenase-1.
- Author
-
Xia ZY, Gao J, Ancharaz AK, Liu KX, Xia Z, Luo T, Xia, Zhong-yuan, Gao, Jin, Ancharaz, Ameer Kumar, Liu, Ke-xuan, Xia, Zhengyuan, and Luo, Tao
- Abstract
Objective: The emergence of ischaemic post-conditioning (IPO) provides a potential method for experimentally and clinically attenuating various types of organ injuries. There has been little work, however, examining its effects in the setting of lung ischaemia reperfusion (IR). The stress protein, haeme oxygenase-1 (HO-1), has been found to exert a potent, protective role in a variety of lung injury models. In this study, we hypothesised that the induction of HO-1 by IPO plays a protective role against the deleterious effects of IR in the lung.Methods: Anaesthetised and mechanically ventilated adult Sprague-Dawley rats were randomly assigned to one of the following groups (n=8 each): the sham-operated control group, the IR group (40 min of left-lung ischaemia and 105 min of reperfusion), the IPO group (three successive cycles of 30-s reperfusion per 30-s occlusion before restoring full perfusion) and the ZnPPIX+IPO group (ZnPPIX, an inhibitor of HO-1, was injected intra-peritoneally at 20 mg kg(-1) 24h prior to the experiment and the rest of the procedures were similar to that of the IPO group). Lung injury was assessed by arterial blood gas analysis, wet-to-dry lung weight ratio and tissue histological changes. The extent of lipid peroxidation was determined by measuring plasma levels of malondialdehyde (MDA) production. Expression of HO-1 was determined by immunohistochemistry.Results: Lung IR resulted in a significant reduction of PaO(2) (data in IR, P<0.05 vs. data in sham) and increase of lung wet-to-dry weight ratio, accompanied with increased MDA production and severe lung pathological morphological changes as well as a compensatory increase in HO-1 protein expression, as compared with sham (All P<0.05). IPO markedly attenuated all the above pathological changes seen in the IR group and further increased HO-1 expression. Treatment with ZnPPIX abolished all the protective effects of post-conditioning.Conclusion: It may be concluded that IPO protects IR-induced lung injury via induction of HO-1. [ABSTRACT FROM AUTHOR]- Published
- 2010
- Full Text
- View/download PDF
31. Inhibiting ATG5 mediated autophagy to regulate endoplasmic reticulum stress and CD4+ T lymphocyte differentiation: Mechanisms of acupuncture's effects on asthma.
- Author
-
Zhao, Huanyi, Dong, Fang, Li, Yuhui, Ren, Xiaojie, Xia, Zhengyuan, Wang, Yong, and Ma, Wuhua
- Subjects
- *
T cell differentiation , *ENDOPLASMIC reticulum , *ASTHMA , *ACUPUNCTURE , *AUTOPHAGY - Abstract
Asthma is characterized by airway hyperresponsiveness(AHR), inflammation and remodeling. Autophagy and endoplasmic reticulum stress(ERS) are dysregulated in asthma, and ATG5 has attracted wide attentions a representative gene of autophagy. Previous evidence shows that acupuncture may treat asthma by regulating the immune environment.However,the precise mechanism involved in acupuncture's effects on asthma is unclear. Thus, we investigated the inner-relationships of acupuncture and ATG5-mediated autophagy, ERS and CD4+ T lymphocyte differentiation in asthma. Ovalbumin (OVA)-sensitized and challenged ATG5+/- and ATG5-/-mice with asthma were treated by acupuncture at Dazhui(GV14),Feishu(BL13) and Zusanli(ST36),and sacrificed the next day.Then blood and bronchoalveolar lavage fluid (BALF)samples were collected to determine inflammatory cell counts and cytokine levels. Lung tissue samples were obtained for histological examination, and the spleen was harvested for flow cytometry. Compared with the untreated group, acupuncture decreased BALF inflammatory cell counts and AHR in OVA-induced mice.Acupuncture decreased autophagy-related protein and mRNA (ATG5,Beclin-1,p62 and LC3B)amounts and ERS-related protein (p-PERK, p-IRE-1,Grp78, and ATF6)levels as well as autophagosome formation in lung tissue, concomitant with increased IFN-γ and decreased IL-4, IL-17 and TGF-β amounts in BALF.Consistently, the imbalance of CD4+ T lymphocyte subsets(Th1/Th2 and Treg/Th17) was also corrected by acupuncture.Meanwhile, AHR and inflammation were decreased in ATG5-/- mice compared with ATG+/-animals,without affecting the therapeutic effect of acupuncture. Acupuncture reduces airway inflammation and AHR in asthma by inhibiting ATG5-mediated autophagy to regulate endoplasmic reticulum stress and CD4+T lymphocyte differentiation. [Display omitted] • Observing the effect of acupuncture treatment on the inflammation and airway hyperresponsiveness of asthma. • Changes of endoplasmic reticulum stress and autophagy in asthma mice model. • Mechanism of acupuncture Inhibiting ATG5 mediated autophagy to regulate differentiation of CD4 + T lymphocytes. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
32. Effect of NO donor sodium nitroprusside on lipopolysaccharide induced acute lung injury in rats
- Author
-
Xia, Zhong-yuan, Wang, Xiao-yuan, Chen, Xiangdong, and Xia, Zhengyuan
- Subjects
- *
NITRIC oxide , *SODIUM nitroferricyanide , *RESPIRATORY organ injuries , *ANIMAL experimentation , *PROTEIN metabolism , *CARDIOVASCULAR agents , *METALLOPORPHYRINS , *ANTHROPOMETRY , *BIOLOGICAL models , *BODY fluids , *COMPARATIVE studies , *DRUG design , *CLINICAL drug trials , *LUNGS , *RESEARCH methodology , *MEDICAL cooperation , *OXIDOREDUCTASES , *OXYGEN , *RATS , *RESEARCH , *ADULT respiratory distress syndrome , *MALONDIALDEHYDE , *EVALUATION research , *LIPOPOLYSACCHARIDES , *PARTIAL pressure , *PREVENTION , *THERAPEUTICS - Abstract
Summary: Nitric oxide (NO) donor-sodium nitroprusside (SNP) mitigates acute lung injury (ALI), but the mechanism of this protection is incompletely known. We investigated the effect of SNP on lipopolysaccharide (LPS)-induced ALI in rats. Forty-eight male Wistar rats were randomly assigned into six groups: the sham-operation group (S group), the LPS instillation group (LPS group), the haemin, a haeme oxygenase-1 (HO-1) inducer, pretreatment group (HM group), the haemin pretreatment plus LPS instillation group (HM+LPS group), the SNP alone and SNP plus LPS treatment groups. Macroscopic and histopathological examinations and immunohistochemistry analysis were performed for the lung specimens 8h after LPS instillation. Intratracheal administration of LPS induced significant expressions of the inducible isoform of NO synthase (iNOS) and HO-1, while both haemin pretreatment and SNP treatment increased the expression of HO-1 and prevented the expression of iNOS. In the LPS group, the wet–dry weight ratio (W/D), bronchoalveolar lavage fluid (BALF) protein, and lung malondialdehyde (MDA) content were significantly higher than those in the sham-operation group, which were reversed by the pretreatment with haemin or administration of SNP. These results suggest that HO-1 plays a protective role against LPS-induced acute lung injury, which may be achieved at least in part, via inactivating the iNOS/NO system that is involved in the pathophysiological process of LPS-induced acute lung injury. The nitric oxide (NO) donor-SNP ameliorates LPS-induced ALI, which may be related to the induction of HO-1 and the subsequent inhibition of iNOS. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
33. PI-35 - Adipocyte fatty acid binding protein (A-FABP) is a potential mediator of heart dysfunction and failure related to obesity.
- Author
-
Hoo, Ruby Lai-chong, Zhou, Mi, Pan, Yong, Shu, Lingling, Sung, Cecilia Y.J., Zhong, Dan, Xia, Zhengyuan, Lam, Karen Siu-ling, and Xu, Aimin
- Subjects
- *
FATTY acid-binding proteins , *HEART diseases , *OBESITY - Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.